{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:13:55Z","timestamp":1790266435089,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T00:00:00Z","timestamp":1490227200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T00:00:00Z","timestamp":1490227200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["T32 ES007051"],"award-info":[{"award-number":["T32 ES007051"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00213-017-4587-8","type":"journal-article","created":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T22:19:25Z","timestamp":1490307565000},"page":"1803-1813","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Phosphodiesterase-1b (Pde1b) knockout mice are resistant to forced swim and tail suspension induced immobility and show upregulation of Pde10a"],"prefix":"10.1007","volume":"234","author":[{"given":"Jillian R.","family":"Hufgard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Skelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivera","family":"Grubisha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipa M.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Sanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy M.","family":"Reed-Kessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald S.","family":"Duman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles V.","family":"Vorhees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,23]]},"reference":[{"key":"4587_CR1","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0022-3999(02)00304-5","volume":"53","author":"P Cassano","year":"2002","unstructured":"Cassano P, Fava M (2002) Depression and public health: an overview. J Psychosom Res 53:849\u2013857","journal-title":"J Psychosom Res"},{"key":"4587_CR2","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1007\/s00125-010-2019-y","volume":"54","author":"T Castaneda","year":"2011","unstructured":"Castaneda T, Nogueiras R, M\u00fcller T, Krishna R, Grant E, Jones A, Ottaway N, Ananthakrishnan G, Pfluger P, Chaudhary N (2011) Decreased glucose tolerance and plasma adiponectin: resistin ratio in a mouse model of post-traumatic stress disorder. Diabetologia 54:900\u2013909","journal-title":"Diabetologia"},{"key":"4587_CR3","doi-asserted-by":"crossref","unstructured":"Chaudhury D, Walsh JJ, Friedman AK, Juarez B, Ku SM, Koo JW, Ferguson D, Tsai H-C, Pomeranz L, Christoffel DJ (2013) Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons. Nature 493:532\u2013536","DOI":"10.1038\/nature11713"},{"key":"4587_CR4","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1146\/annurev.biochem.76.060305.150444","volume":"76","author":"M Conti","year":"2007","unstructured":"Conti M, Beavo J (2007) Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. Annu Rev Biochem 76:481\u2013511","journal-title":"Annu Rev Biochem"},{"key":"4587_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/dev.420070110","volume":"7","author":"RW Cravens","year":"1974","unstructured":"Cravens RW (1974) Effects of maternal undernutrition on offspring behavior: incentive value of a food reward and ability to escape from water. Dev Psychobiol 7:61\u201369","journal-title":"Dev Psychobiol"},{"key":"4587_CR6","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","volume":"29","author":"JF Cryan","year":"2005","unstructured":"Cryan JF, Mombereau C, Vassout A (2005a) The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 29:571\u2013625","journal-title":"Neurosci Biobehav Rev"},{"key":"4587_CR7","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.neubiorev.2005.03.008","volume":"29","author":"JF Cryan","year":"2005","unstructured":"Cryan JF, Valentino RJ, Lucki I (2005b) Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev 29:547\u2013569","journal-title":"Neurosci Biobehav Rev"},{"key":"4587_CR8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1472-8206.2008.00605.x","volume":"22","author":"A Dhir","year":"2008","unstructured":"Dhir A, Kulkarni S (2008) Possible involvement of sigma-1 receptors in the anti-immobility action of bupropion, a dopamine reuptake inhibitor. Fundamental & clinical pharmacology 22:387\u2013394","journal-title":"Fundamental & clinical pharmacology"},{"key":"4587_CR9","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.neuropharm.2007.12.002","volume":"54","author":"D Dlaboga","year":"2008","unstructured":"Dlaboga D, Hajjhussein H, O\u2019Donnell JM (2008) Chronic haloperidol and clozapine produce different patterns of effects on phosphodiesterase-1B,-4B, and-10A expression in rat striatum. Neuropharmacology 54:745\u2013754","journal-title":"Neuropharmacology"},{"key":"4587_CR10","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/S0006-3223(99)00177-8","volume":"46","author":"RS Duman","year":"1999","unstructured":"Duman RS, Malberg J, Thome J (1999) Neural plasticity to stress and antidepressant treatment. Biol Psychiatry 46:1181\u20131191","journal-title":"Biol Psychiatry"},{"key":"4587_CR11","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1601-183X.2006.00209.x","volume":"5","author":"L Ehrman","year":"2006","unstructured":"Ehrman L, Williams M, Schaefer T, Gudelsky G, Reed T, Fienberg A, Greengard P, Vorhees C (2006) Phosphodiesterase 1B differentially modulates the effects of methamphetamine on locomotor activity and spatial learning through DARPP32-dependent pathways: evidence from PDE1B-DARPP32 double-knockout mice. Genes Brain Behav 5:540\u2013551","journal-title":"Genes Brain Behav"},{"key":"4587_CR12","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1067\/mai.2001.119555","volume":"108","author":"DM Essayan","year":"2001","unstructured":"Essayan DM (2001) Cyclic nucleotide phosphodiesterases. J Allergy Clin Immunol 108:671\u2013680","journal-title":"J Allergy Clin Immunol"},{"key":"4587_CR13","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1126\/science.281.5378.838","volume":"281","author":"A Fienberg","year":"1998","unstructured":"Fienberg A, Hiroi N, Mermelstein P, Song W-J, Snyder G, Nishi A, Cheramy A, O\u2019callaghan J, Miller D, Cole D (1998) DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science 281:838\u2013842","journal-title":"Science"},{"key":"4587_CR14","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.neulet.2010.02.046","volume":"473","author":"CC Filgueiras","year":"2010","unstructured":"Filgueiras CC, Krahe TE, Medina AE (2010) Phosphodiesterase type 1 inhibition improves learning in rats exposed to alcohol during the third trimester equivalent of human gestation. Neurosci Lett 473:202\u2013207","journal-title":"Neurosci Lett"},{"key":"4587_CR15","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.biopsych.2012.04.030","volume":"72","author":"M Fujita","year":"2012","unstructured":"Fujita M, Hines CS, Zoghbi SS, Mallinger AG, Dickstein LP, Liow J-S, Zhang Y, Pike VW, Drevets WC, Innis RB (2012) Downregulation of brain phosphodiesterase type IV measured with 11C-(R)-rolipram positron emission tomography in major depressive disorder. Biol Psychiatry 72:548\u2013554","journal-title":"Biol Psychiatry"},{"key":"4587_CR16","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.neuroscience.2009.11.046","volume":"165","author":"U G\u00f3mez-Pinedo","year":"2010","unstructured":"G\u00f3mez-Pinedo U, Rodrigo R, Cauli O, Herraiz S, Garcia-Verdugo J-M, Pellicer B, Pellicer A, Felipo V (2010) cGMP modulates stem cells differentiation to neurons in brain in vivo. Neuroscience 165:1275\u20131283","journal-title":"Neuroscience"},{"key":"4587_CR17","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1124\/jpet.109.155994","volume":"331","author":"SM Grauer","year":"2009","unstructured":"Grauer SM, Pulito VL, Navarra RL, Kelly MP, Kelley C, Graf R, Langen B, Logue S, Brennan J, Jiang L (2009) Phosphodiesterase 10A inhibitor activity in preclinical models of the positive, cognitive, and negative symptoms of schizophrenia. J Pharmacol Exp Ther 331:574\u2013590","journal-title":"J Pharmacol Exp Ther"},{"key":"4587_CR18","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.4088\/JCP.v64n1211","volume":"64","author":"PE Greenberg","year":"2003","unstructured":"Greenberg PE, Kessler RC, Birnbaum HG, Leong SA, Lowe SW, Berglund PA, Corey-Lisle PK (2003) The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry 64:1465\u20131475","journal-title":"J Clin Psychiatry"},{"key":"4587_CR19","doi-asserted-by":"publisher","first-page":"22337","DOI":"10.1074\/jbc.274.32.22337","volume":"274","author":"P Han","year":"1999","unstructured":"Han P, Werber J, Surana M, Fleischer N, Michaeli T (1999) The calcium\/calmodulin-dependent phosphodiesterase PDE1C down-regulates glucose-induced insulin secretion. J Biol Chem 274:22337\u201322344","journal-title":"J Biol Chem"},{"key":"4587_CR20","first-page":"291","volume":"21","author":"R Hansen","year":"2015","unstructured":"Hansen R, Zhang H-T (2015) Phosphodiesterase-4 modulation as a potential therapeutic for cognitive loss in pathological and non-pathological aging: possibilities and pitfalls. Curr Pharm Des 21:291\u2013302","journal-title":"Curr Pharm Des"},{"key":"4587_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10545-013-9619-x","volume":"37","author":"ER Hautman","year":"2014","unstructured":"Hautman ER, Kokenge AN, Udobi KC, Williams MT, Vorhees CV, Skelton MR (2014) Female mice heterozygous for creatine transporter deficiency show moderate cognitive deficits. J Inherit Metab Dis 37:63\u201368","journal-title":"J Inherit Metab Dis"},{"key":"4587_CR22","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.coph.2006.08.014","volume":"7","author":"AL Hebb","year":"2007","unstructured":"Hebb AL, Robertson HA (2007) Role of phosphodiesterases in neurological and psychiatric disease. Curr Opin Pharmacol 7:86\u201392","journal-title":"Curr Opin Pharmacol"},{"key":"4587_CR23","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.1021\/jm1002793","volume":"53","author":"N H\u00f6fgen","year":"2010","unstructured":"H\u00f6fgen N, Stange H, Schindler R, Lankau H-J, Grunwald C, Langen B, Egerland U, Tremmel P, Pangalos MN, Marquis KL (2010) Discovery of imidazo [1, 5-a] pyrido [3, 2-e] pyrazines as a new class of phosphodiesterase 10A inhibitors. J Med Chem 53:4399\u20134411","journal-title":"J Med Chem"},{"key":"4587_CR24","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ejphar.2012.05.051","volume":"689","author":"A Jindal","year":"2012","unstructured":"Jindal A, Mahesh R, Gautam B, Bhatt S, Pandey D (2012) Antidepressant-like effect of etazolate, a cyclic nucleotide phosphodiesterase 4 inhibitor\u2014an approach using rodent behavioral antidepressant tests battery. Eur J Pharmacol 689:125\u2013131","journal-title":"Eur J Pharmacol"},{"key":"4587_CR25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.pbb.2013.01.020","volume":"105","author":"A Jindal","year":"2013","unstructured":"Jindal A, Mahesh R, Bhatt S (2013) Etazolate, a phosphodiesterase 4 inhibitor reverses chronic unpredictable mild stress-induced depression-like behavior and brain oxidative damage. Pharmacol Biochem Behav 105:63\u201370","journal-title":"Pharmacol Biochem Behav"},{"key":"4587_CR26","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.cellsig.2013.10.007","volume":"26","author":"MP Kelly","year":"2014","unstructured":"Kelly MP, Adamowicz W, Bove S, Hartman AJ, Mariga A, Pathak G, Reinhart V, Romegialli A, Kleiman RJ (2014) Select 3\u2032, 5\u2032-cyclic nucleotide phosphodiesterases exhibit altered expression in the aged rodent brain. Cell Signal 26:383\u2013397","journal-title":"Cell Signal"},{"key":"4587_CR27","doi-asserted-by":"crossref","unstructured":"Kennedy SH (2013) A review of antidepressant therapy in primary care: current practices and future directions. The Primary Care Companion for CNS Disorders 15","DOI":"10.4088\/PCC.12r01420"},{"key":"4587_CR28","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1161\/hc4401.098432","volume":"104","author":"D Kim","year":"2001","unstructured":"Kim D, Rybalkin SD, Pi X, Wang Y, Zhang C, Munzel T, Beavo JA, Berk BC, Yan C (2001) Upregulation of phosphodiesterase 1A1 expression is associated with the development of nitrate tolerance. Circulation 104:2338\u20132343","journal-title":"Circulation"},{"key":"4587_CR29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1124\/jpet.110.173294","volume":"336","author":"RJ Kleiman","year":"2011","unstructured":"Kleiman RJ, Kimmel LH, Bove SE, Lanz TA, Harms JF, Romegialli A, Miller KS, Willis A, des Etages S, Kuhn M (2011) Chronic suppression of phosphodiesterase 10A alters striatal expression of genes responsible for neurotransmitter synthesis, neurotransmission, and signaling pathways implicated in Huntington\u2019s disease. J Pharmacol Exp Ther 336:64\u201376","journal-title":"J Pharmacol Exp Ther"},{"key":"4587_CR30","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.neuropharm.2010.05.004","volume":"59","author":"V Lakics","year":"2010","unstructured":"Lakics V, Karran EH, Boess FG (2010) Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues. Neuropharmacology 59:367\u2013374","journal-title":"Neuropharmacology"},{"key":"4587_CR31","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1021\/acs.jmedchem.5b01751","volume":"59","author":"P Li","year":"2016","unstructured":"Li P, Zheng H, Zhao J, Zhang L, Yao W, Zhu H, Beard JD, Ida K, Lane W, Snell G (2016) Discovery of potent and selective inhibitors of phosphodiesterase 1 for the treatment of cognitive impairment associated with neurodegenerative and neuropsychiatric diseases. J Med Chem 59:1149\u20131164","journal-title":"J Med Chem"},{"key":"4587_CR32","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.ejphar.2008.11.010","volume":"602","author":"SS Mason","year":"2009","unstructured":"Mason SS, Baker KB, Davis KW, Pogorelov VM, Malbari MM, Ritter R, Wray SP, Gerhardt B, Lanthorn TH, Savelieva KV (2009) Differential sensitivity to SSRI and tricyclic antidepressants in juvenile and adult mice of three strains. Eur J Pharmacol 602:306\u2013315","journal-title":"Eur J Pharmacol"},{"key":"4587_CR33","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrd4228","volume":"13","author":"DH Maurice","year":"2014","unstructured":"Maurice DH, Ke H, Ahmad F, Wang Y, Chung J, Manganiello VC (2014) Advances in targeting cyclic nucleotide phosphodiesterases. Nat Rev Drug Discov 13:290\u2013314","journal-title":"Nat Rev Drug Discov"},{"key":"4587_CR34","doi-asserted-by":"publisher","first-page":"e376","DOI":"10.1038\/tp.2014.17","volume":"4","author":"S Natesan","year":"2014","unstructured":"Natesan S, Ashworth S, Nielsen J, Tang S, Salinas C, Kealey S, Lauridsen J, Stensb\u00f8l T, Gunn R, Rabiner E (2014) Effect of chronic antipsychotic treatment on striatal phosphodiesterase 10A levels: a [11C] MP-10 PET rodent imaging study with ex vivo confirmation. Transl Psychiatry 4:e376","journal-title":"Transl Psychiatry"},{"key":"4587_CR35","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.tips.2004.01.003","volume":"25","author":"JM O\u2019Donnell","year":"2004","unstructured":"O\u2019Donnell JM, Zhang H-T (2004) Antidepressant effects of inhibitors of cAMP phosphodiesterase (PDE4). Trends Pharmacol Sci 25:158\u2013163","journal-title":"Trends Pharmacol Sci"},{"key":"4587_CR36","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1523\/JNEUROSCI.14-03-01251.1994","volume":"14","author":"JW Polli","year":"1994","unstructured":"Polli JW, Kincaid RL (1994) Expression of a calmodulin-dependent phosphodiesterase isoform (PDE1B1) correlates with brain regions having extensive dopaminergic innervation. J Neurosci 14:1251\u20131261","journal-title":"J Neurosci"},{"key":"4587_CR37","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0014-2999(79)90366-2","volume":"57","author":"RD Porsolt","year":"1979","unstructured":"Porsolt RD, Bertin A, Blavet N, Deniel M, Jalfre M (1979) Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity. Eur J Pharmacol 57:201\u2013210","journal-title":"Eur J Pharmacol"},{"key":"4587_CR38","unstructured":"Reed TM (2000) Characterization of phosphodiesterase 1B-deficient mice: role of PDE1B in central nervous system function. ProQuest Dissertations & Theses"},{"key":"4587_CR39","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.1523\/JNEUROSCI.22-12-05188.2002","volume":"22","author":"TM Reed","year":"2002","unstructured":"Reed TM, Repaske DR, Snyder GL, Greengard P, Vorhees CV (2002) Phosphodiesterase 1B knock-out mice exhibit exaggerated locomotor hyperactivity and DARPP-32 phosphorylation in response to dopamine agonists and display impaired spatial learning. J Neurosci 22:5188\u20135197","journal-title":"J Neurosci"},{"key":"4587_CR40","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2174\/157015911798376271","volume":"9","author":"GW Reierson","year":"2011","unstructured":"Reierson GW, Guo S, Mastronardi C, Licinio J, Wong M-L (2011) cGMP signaling, phosphodiesterases and major depressive disorder. Curr Neuropharmacol 9:715","journal-title":"Curr Neuropharmacol"},{"key":"4587_CR41","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1161\/hh0202.104108","volume":"90","author":"SD Rybalkin","year":"2002","unstructured":"Rybalkin SD, Rybalkina I, Beavo JA, Bornfeldt KE (2002) Cyclic nucleotide phosphodiesterase 1C promotes human arterial smooth muscle cell proliferation. Circ Res 90:151\u2013157","journal-title":"Circ Res"},{"key":"4587_CR42","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/j.1601-183X.2012.00796.x","volume":"11","author":"T Schaefer","year":"2012","unstructured":"Schaefer T, Braun A, Amos-Kroohs R, Williams M, Ostertag E, Vorhees C (2012) A new model of Pde4d deficiency: genetic knock-down of PDE4D enzyme in rats produces an antidepressant phenotype without spatial cognitive effects. Genes Brain Behav 11:614\u2013622","journal-title":"Genes Brain Behav"},{"key":"4587_CR43","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1124\/jpet.107.132910","volume":"325","author":"CJ Schmidt","year":"2008","unstructured":"Schmidt CJ, Chapin DS, Cianfrogna J, Corman ML, Hajos M, Harms JF, Hoffman WE, Lebel LA, McCarthy SA, Nelson FR (2008) Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophrenia. J Pharmacol Exp Ther 325:681\u2013690","journal-title":"J Pharmacol Exp Ther"},{"key":"4587_CR44","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.neuropharm.2006.04.013","volume":"51","author":"JA Siuciak","year":"2006","unstructured":"Siuciak JA, Chapin DS, Harms JF, Lebel LA, McCarthy SA, Chambers L, Shrikhande A, Wong S, Menniti FS, Schmidt CJ (2006a) Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis. Neuropharmacology 51:386\u2013396","journal-title":"Neuropharmacology"},{"key":"4587_CR45","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.neuropharm.2006.01.012","volume":"51","author":"JA Siuciak","year":"2006","unstructured":"Siuciak JA, McCarthy SA, Chapin DS, Fujiwara RA, James LC, Williams RD, Stock JL, McNeish JD, Strick CA, Menniti FS (2006b) Genetic deletion of the striatum-enriched phosphodiesterase PDE10A: evidence for altered striatal function. Neuropharmacology 51:374\u2013385","journal-title":"Neuropharmacology"},{"key":"4587_CR46","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.neuropharm.2007.04.009","volume":"53","author":"JA Siuciak","year":"2007","unstructured":"Siuciak JA, McCarthy SA, Chapin DS, Reed T, Vorhees C, Repaske D (2007) Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-1B (PDE1B) enzyme. Neuropharmacology 53:113\u2013124","journal-title":"Neuropharmacology"},{"key":"4587_CR47","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00213-007-1014-6","volume":"197","author":"JA Siuciak","year":"2008","unstructured":"Siuciak JA, McCarthy SA, Chapin DS, Martin AN (2008) Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-4B (PDE4B) enzyme. Psychopharmacology 197:115\u2013126","journal-title":"Psychopharmacology"},{"key":"4587_CR48","doi-asserted-by":"crossref","unstructured":"Snyder GL, Prickaerts J, Wadenberg M-L, Zhang L, Zheng H, Yao W, Akkerman S, Zhu H, Hendrick JP, Vanover KE (2016) Preclinical profile of ITI-214, an inhibitor of phosphodiesterase 1, for enhancement of memory performance in rats. Psychopharmacology: 1\u201312","DOI":"10.1007\/s00213-016-4346-2"},{"key":"4587_CR49","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature18285","volume":"534","author":"TS Stappenbeck","year":"2016","unstructured":"Stappenbeck TS, Virgin HW (2016) Accounting for reciprocal host\u2013microbiome interactions in experimental science. Nature 534:191\u2013199","journal-title":"Nature"},{"key":"4587_CR50","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1073\/pnas.97.4.1856","volume":"97","author":"P Svenningsson","year":"2000","unstructured":"Svenningsson P, Lindskog M, Ledent C, Parmentier M, Greengard P, Fredholm BB, Fisone G (2000) Regulation of the phosphorylation of the dopamine-and cAMP-regulated phosphoprotein of 32\u00a0kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. Proc Natl Acad Sci 97:1856\u20131860","journal-title":"Proc Natl Acad Sci"},{"key":"4587_CR51","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.1073\/pnas.052712699","volume":"99","author":"P Svenningsson","year":"2002","unstructured":"Svenningsson P, Tzavara ET, Liu F, Fienberg AA, Nomikos GG, Greengard P (2002) DARPP-32 mediates serotonergic neurotransmission in the forebrain. Proc Natl Acad Sci 99:3188\u20133193","journal-title":"Proc Natl Acad Sci"},{"key":"4587_CR52","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1126\/science.1089681","volume":"302","author":"P Svenningsson","year":"2003","unstructured":"Svenningsson P, Tzavara ET, Carruthers R, Rachleff I, Wattler S, Nehls M, McKinzie DL, Fienberg AA, Nomikos GG, Greengard P (2003) Diverse psychotomimetics act through a common signaling pathway. Science 302:1412\u20131415","journal-title":"Science"},{"key":"4587_CR53","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1146\/annurev.pharmtox.44.101802.121415","volume":"44","author":"P Svenningsson","year":"2004","unstructured":"Svenningsson P, Nishi A, Fisone G, Girault J-A, Nairn AC, Greengard P (2004) DARPP-32: an integrator of neurotransmission. Annu Rev Pharmacol Toxicol 44:269\u2013296","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"4587_CR54","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1111\/j.1476-5381.2012.02225.x","volume":"168","author":"ZZ Wang","year":"2013","unstructured":"Wang ZZ, Zhang Y, Liu YQ, Zhao N, Zhang YZ, Yuan L, An L, Li J, Wang XY, Qin JJ (2013) RNA interference-mediated phosphodiesterase 4D splice variants knock-down in the prefrontal cortex produces antidepressant-like and cognition-enhancing effects. Br J Pharmacol 168:1001\u20131014","journal-title":"Br J Pharmacol"},{"key":"4587_CR55","doi-asserted-by":"crossref","unstructured":"Xu Y, Zhang H-T, O\u2019Donnell JM (2011) Phosphodiesterases in the central nervous system: implications in mood and cognitive disorders. Phosphodiesterases as Drug Targets. Springer, pp 447\u2013485","DOI":"10.1007\/978-3-642-17969-3_19"},{"key":"4587_CR56","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1017\/S146114571200065X","volume":"16","author":"Y Xu","year":"2013","unstructured":"Xu Y, Pan J, Chen L, Zhang C, Sun J, Li J, Nguyen L, Nair N, Zhang H, O\u2019Donnell JM (2013) Phosphodiesterase-2 inhibitor reverses corticosterone-induced neurotoxicity and related behavioural changes via cGMP\/PKG dependent pathway. Int J Neuropsychopharmacol 16:835\u2013847","journal-title":"Int J Neuropsychopharmacol"},{"key":"4587_CR57","first-page":"587","volume":"27","author":"H-T Zhang","year":"2002","unstructured":"Zhang H-T, Huang Y, Jin SC, Frith SA, Suvarna N, Conti M, James M (2002) Antidepressant-like profile and reduced sensitivity to rolipram in mice deficient in the PDE4D phosphodiesterase enzyme. Neuropsychopharmacology 27:587\u2013595","journal-title":"Neuropsychopharmacology"},{"key":"4587_CR58","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1038\/sj.npp.1301537","volume":"33","author":"H-T Zhang","year":"2008","unstructured":"Zhang H-T, Huang Y, Masood A, Stolinski LR, Li Y, Zhang L, Dlaboga D, Jin SC, Conti M, O\u2019Donnell JM (2008) Anxiogenic-like behavioral phenotype of mice deficient in phosphodiesterase 4B (PDE4B). Neuropsychopharmacology 33:1611\u20131623","journal-title":"Neuropsychopharmacology"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-017-4587-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-017-4587-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-017-4587-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T09:04:30Z","timestamp":1589619870000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-017-4587-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,23]]},"references-count":58,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["4587"],"URL":"https:\/\/doi.org\/10.1007\/s00213-017-4587-8","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,23]]},"assertion":[{"value":"11 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Protocols were approved by the Institutional Animal Care and Use Committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Kurt Rasmussen, Olivera Grubisha, Filipa M. Ferreira, and Helen Sanger are employees of Eli Lilly & Company. No Eli Lilly-supplied products were used in the experiments reported herein. All other authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}